子宫内膜癌中的雌激素和孕激素受体:我们今天在哪里?

Surgery, gynecology & obstetrics Pub Date : 2018-01-01 DOI:10.4172/2161-0932.1000E127

Swasti

{"title":"子宫内膜癌中的雌激素和孕激素受体:我们今天在哪里?","authors":"Swasti","doi":"10.4172/2161-0932.1000E127","DOIUrl":null,"url":null,"abstract":"Immunohistochemistry of estrogen receptor (ER) and progesterone receptor (PR) is not routinely adopted by clinicians for the management of endometrial cancers. However, they may have significant importance in determining tumor behaviour and selection of an appropriate treatment protocol. An insight into the role of ER and PR in endometrial cancers is needed for optimizing outcome. The mechanism of action of these receptors in endometrial carcinoma needs to be clearly understood.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"15 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Estrogen and Progesterone Receptors in Endometrial Cancer: Where Are We Today?\",\"authors\":\"Swasti\",\"doi\":\"10.4172/2161-0932.1000E127\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Immunohistochemistry of estrogen receptor (ER) and progesterone receptor (PR) is not routinely adopted by clinicians for the management of endometrial cancers. However, they may have significant importance in determining tumor behaviour and selection of an appropriate treatment protocol. An insight into the role of ER and PR in endometrial cancers is needed for optimizing outcome. The mechanism of action of these receptors in endometrial carcinoma needs to be clearly understood.\",\"PeriodicalId\":22164,\"journal\":{\"name\":\"Surgery, gynecology & obstetrics\",\"volume\":\"15 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgery, gynecology & obstetrics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2161-0932.1000E127\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery, gynecology & obstetrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2161-0932.1000E127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 4

摘要

雌激素受体(ER)和孕激素受体(PR)的免疫组化并不是临床医生治疗子宫内膜癌的常规方法。然而，它们在确定肿瘤行为和选择适当的治疗方案方面可能具有重要意义。需要深入了解ER和PR在子宫内膜癌中的作用，以优化结果。这些受体在子宫内膜癌中的作用机制有待明确。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Estrogen and Progesterone Receptors in Endometrial Cancer: Where Are We Today?

Immunohistochemistry of estrogen receptor (ER) and progesterone receptor (PR) is not routinely adopted by clinicians for the management of endometrial cancers. However, they may have significant importance in determining tumor behaviour and selection of an appropriate treatment protocol. An insight into the role of ER and PR in endometrial cancers is needed for optimizing outcome. The mechanism of action of these receptors in endometrial carcinoma needs to be clearly understood.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Surgery, gynecology & obstetrics

自引率

0.00%

发文量

期刊最新文献

Psychological Status of Clinical Laboratory Staff During the COVID-19 Outbreak. Exhibitors to Bleeding Disorders in the Context of Pre-Eclampsia: Analytical Preliminary Study About 50 Cases at Laquintinie Hospital (Douala, Cameroon) Congenital lobar emphysema. Fibromuscular dysplasia. Package.